AMAG Pharmaceuticals

GlobalMed named Arizona Bioscience Company of the Year

Thursday, September 8, 2016

The Arizona Bioindustry Association (AZBio) will honor GlobalMed as the Arizona Bioscience Company of the Year at the 2016 AZBio Awards on September 21, 2016. Hundreds of Arizona life science and business leaders as well as guests from across the country will be on hand at the Phoenix Convention Center to recognize GlobalMed for the many ways that the team, the company and their technology are making life better for people here in Arizona and around the world.

[Read More]

Veristat adds Mark Chang as SVP of Strategic Statistical Consulting

Friday, June 17, 2016

Veristat, a full service CRO, has strengthened its statistical consulting and adaptive design expertise with the appointment of Mark Chang, Ph.D., to the newly created position of senior vice president of Strategic Statistical Consulting. Dr. Chang will help clients evaluate and implement strategic, operational and technical efficiencies to advance products through the clinical trial and regulatory submission process.

[Read More]

AMAG Pharmaceuticals acquires Lumara Health’s Maternal Health Business

Wednesday, July 1, 2015

AMAG Pharmaceuticals, a Massachusetts-based specialty pharmaceutical company, has completed the acquisition of Lumara Health, a St. Louis, Mo.-based specialty pharmaceutical company with a particular focus on maternal health. The transaction was announced on September 29, 2014 and included upfront consideration of $600 million in cash and 3,209,971 shares of AMAG common stock, and additional contingent consideration of up to $350 million based on the achievement of sales milestones. 

[Read More]

Cubist Pharmaceuticals names Robert J. Perez CEO

Thursday, October 23, 2014

Cubist Pharmaceuticals has selected Robert J. Perez as the company’s CEO, effective January, 2015. Perez, who currently is Cubist’s president and chief operating officer, will succeed Michael W. Bonney who is retiring from his current role as CEO on Dec. 31, and will become non-executive chair of Cubist’s board of directors. Current board chair Kenneth M. Bate will become lead independent director.

[Read More]